Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  EntreMed Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer and inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The Company operates through one business segment, which is the development of targeted therapeutics primarily for the treatment of cancer.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD582012Chief Executive Officer & Director
Wei-Wu He PhD, MBA522012Executive Chairman
Cynthia Wong Hu472006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA502011Chief Accounting Officer & Vice President-Finance
Rong Chen MD, PhD-2015Chief Medical Officer
Zuie Chin Huang, MBA522013Independent Director
Yue Alexander Wu PhD, MBA532013Independent Director
Franklin Cary Salisbury, Jr.612014Independent Director
Rajesh C. Shrotriya, MD732014Independent Director
Quan Zhou, PhD592016Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 60,276,119 33,568,939 55.7% 79,545 0.1% 55.7%
Shareholders
NameEquities%
Spectrum Pharmaceuticals, Inc. 10,028,579 16.7%
He Xie Ai Qi Investment Management Beijing Co. Ltd. 8,498,765 14.1%
IDG Capital Partners Co., Ltd. 6,842,783 11.4%
Zhejiang Kanglaite Group Co. Ltd. 2,469,135 4.10%
Celgene Corp. 2,464,987 4.09%
Emerging Technology Partners LLC 2,312,677 3.84%
Wellington Shields Capital Management LLC 557,268 0.93%
Wellington Shields & Co. LLC 505,474 0.84%
Kleiner Perkins Caufield & Byers LLC 416,666 0.69%
The Vanguard Group, Inc. 366,642 0.61%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research - NEC
1st jan.Capitalization (M$)
ENTREMED INC75
INCYTE CORPORATION17.43%22 182
QUINTILES IMS HOLDINGS..1.46%18 995
CELLTRION, INC.--.--%10 712
LONZA GROUP AG4.65%9 715
ALKERMES PLC-0.22%8 428
SEATTLE GENETICS, INC.12.03%8 369
QIAGEN NV1.18%6 796
UNITED THERAPEUTICS CO..4.73%6 372
IONIS PHARMACEUTICALS ..0.54%5 829
ICON PLC9.16%4 602
ACADIA PHARMACEUTICALS..10.16%3 848
CHARLES RIVER LABORATO..5.71%3 812
PAREXEL INTERNATIONAL ..8.41%3 795
BIO-TECHNE CORP-1.40%3 783
ALNYLAM PHARMACEUTICAL..11.11%3 570
PRA HEALTH SCIENCES IN..4.48%3 537
GALAPAGOS7.45%3 223
BB BIOTECH AG2.18%3 092
INTREXON CORP1.93%2 937
INC RESEARCH HOLDINGS ..-2.19%2 759
Sector Biotechnology & Medical Research - NEC
EntreMed Inc : Connections
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2017 People , Fundamentals and Ownership